Iskalni niz:
išči po
išči po
išči po
išči po
Vrsta gradiva:
Jezik:
Št. zadetkov: 4
Sporadic hepatitis A virus PCR false-positive results observed during reflex testing of serum samples previously tested for Anti-HAV antibodies and caused by contamination with HAV RNA present in the reagents of the commercial Anti-HAV immunoassay
Maja M. Lunar, Petra Markočič, Kristina Fujs Komloš, Tina Močilnik, Mario Poljak, Mario Poljak
Izvirni znanstveni članek
Oznake: patogeni mikroorganizmi;Campylobacter jejuni;luxS;hepatitis A virus;intercellular signaling;
Hepatitis A diagnosis relies on serology and occasionally on hepatitis A virus (HAV) RNA detection. For timely diagnosis and the avoidance of drawing additional blood, molecular testing is often performed as reflex testing by using blood specimens that were initially sent for anti-HAV serology. Refl ...
Leto: 2023 Vir: Medicinska fakulteta (UL MF)
Humani virusi papiloma (HPV)
Mario Poljak, Boštjan Kocjan, Katja Seme, Kristina Fujs Komloš, Marko Potočnik, Boštjan Luzar, Nina Gale
Strokovni članek
Oznake:
Humani virusi papiloma (HPV)
Leto: 2005 Vir: Onkološki inštitut Ljubljana (OI)
Real-life head-to-head comparison of performance of two high-throughput automated assays for detection of SARS-CoV-2 RNA in nasopharyngeal swabs
Rok Kogoj, Petra Kmetič, Anja Oštrbenk, Kristina Fujs Komloš, Katja Seme, Martin Sagadin, Miša Korva, Mario Poljak
Izvirni znanstveni članek
Oznake: SARS-CoV2;molecular analyzer;Abbott's Alinity M;
Abbott's Alinity m is a recently launched fully integrated, automated molecular analyzer allowing continuous loading of samples and sample-to-result molecular detection of several microorganisms. Manufacturer-independent clinical evaluation of Alinity m SARS-CoV-2 (Alinity) against cobas 6800 SARS-C ...
Leto: 2021 Vir: Medicinska fakulteta (UL MF)
Impaired booster-induced SARS-CoV-2 antibody responses in rituximab-treated B-cell lymphoma patients despite peripheral B-Cell Recovery
Tomaž Jurca, Lučka Boltežar, Miha Oražem, Kristina Fujs Komloš, Katka Pohar, Sara Jevnikar, Mario Poljak, Denis Mlakar-Mastnak, Nada Rotovnik-Kozjek, Bor Vratanar, Janja Ocvirk, Alojz Ihan
Izvirni znanstveni članek
Oznake: limfom;B-celični limfom;rituksimab;cepljenje proti covid-19;lymphoma;B-cell;rituximab;COVID-19 vaccines;
Rituximab-treated patients with B-cell lymphoma exhibit profound B-cell depletion and impaired vaccine-induced antibody responses. However, it remains uncertain whether recovery of peripheral B-cell counts after rituximab is sufficient to restore effective humoral immunity following booster vaccinat ...
Leto: 2026 Vir: Onkološki inštitut Ljubljana (OI)
Št. zadetkov: 4
Ključne besede:
Leto izdaje:
Avtorji:
Repozitorij:
Tipologija:
Jezik: